Wednesday February 10 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Multiple Myeloma News and Headlines
Multiple Myeloma News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Multiple Myeloma
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Multiple Myeloma
.
Non-Homologous End-Joining Gene Profiling Reveals Distinct Expression Patterns Associated with Lymphoma and Multiple Myeloma
British Journal of Haematology:
similar ...
CancersGuide.com Guide to Cancer Treatments, Vaccines, Cancer Tests and Researches
PRLog:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for ...
PipelineReview:
similar ...
Managing Myeloma (www.ManagingMyeloma.com) Multi-supported Educational Initiative Continues to Introduce Excit
Pharma Live:
similar ...
University of Michigan Health System: Blood test could improve graft-versus-host disease treatment
NewsRX:
similar ...
Onyx, FDA Reach Agreement on Multiple Myeloma Drug Trial
FDA News:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Car
Pharmacy Choice:
similar ...
LLS increases maximum benefit for myeloma patients to $10,000
News-Medical.Net:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
SmartBrief:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Earthtimes.org:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
FinanzNachrichten.de:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Street Insider:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib C
NewsBlaze:
similar ...
BRIEF-Onyx announces agreement with FDA on SPA for cancer drug trial
Interactive Investor:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Individual.com:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Twin Cities Business Journal:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
Sacramento Business Journal:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Carfilzomib Combination Trial in Relapsed Multiple Myeloma
San Jose Business Journal:
similar ...
Onyx Pharmaceuticals Announces Agreement with the FDA on a Special Protocol Assessment for Planned Phase 3 Car
Pharma Live:
similar ...
The Leukemia & Lymphoma Society Increases Critical Benefit for Myeloma Patients
Triangle Business Journal:
similar ...
